Drugs Policy in Developing Countries

Häftad, Engelska, 1992

469 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

This policy-relevant study grew out of an evaluation conducted by its authors - all scholars at the London School of Hygiene & Tropical Medicine and the Royal Tropical Institute, Amsterdam - of the World Health Organization's Action Programme on Essential Drugs. Their review, involving 13 country studies and WHO's five regional offices, looks at how the idea of a rational drug policy in developing countries came about, evaluates the achievements in specific countries, and discusses some of the issues that remain to be resolved - particularly issues around AIDs, contraception and cost recovery.It should prove useful to policy makers and academics, teachers and students, managers and professionals, as well as international agencies in the health field.

Produktinformation

Utgivningsdatum1992-09-01
Mått138 x 216 x 8 mm
Vikt201 g
FormatHäftad
SpråkEngelska
Antal sidor152
FörlagBloomsbury Publishing PLC
ISBN9781856490603

Tillhör följande kategorier

Hälsa inom Halsa och familj
Referensverk och tvärvetenskap inom Samhalle och politik
Hälso- och sjukvård inom Medicin
Farmakologi inom Medicin

Najmi Kanji is a research fellow in the Health Policy Unit at the London School of Hygiene & Tropical Medicine.Anita Hardon is a medical biologist in the Medical Anthropology Unit of the University of Amsterdam.Jan Willem Harnmeijer works in the Primary Health Care Unit at the Royal Tropical Institute in Amsterdam.Masuma Mamdani is an epidemiologist and research fellow at the London School of Hygiene & Tropical Medicine.Gill Walt is a senior lecturer and head of the Health Policy Unit at the London School of Hygiene & Tropical Medicine

Tables and FiguresContributorsForeword and AcknowledgementsAcronyms and Abbreviations1. Early Initiatives in Essential Drugs Policy - Masuma Mamdani2. Formulating an Essential Drugs Policy: WHO's Role - Gill Walt and Jan Willem Harnmeijer3. Consumers versus Producers: Power Play Behind the Scenes - Anita Hardon4. Action at Country Level: The International and National Influences - Najmi Kanji5. What Has Been Achieved and Where are We Now? - Najmi Kanji and Anita Hardon6. New Horizons in the 1990s - Anita Hardon and Najmi KanjiAppendixIndex

'Anyone who wants to understand the limitations and constraints of developing and executing a global policy to improve health in developing countries will find this book essential reading.'Calvin M. Kunin, M.D., Department of Internal Medicine, Ohio State University'This book comes as a welcome reminder of the many efforts to develop policies for a more rational use of medecines. It provides a clear outline of some of the possible strategies to achieve change.'Andrew Chetley, author of A Healthy Business: World Health and the Pharmaceutical Industry'The WHO has succeeded in making "essential drugs" a respected concept. This book documents this crucial step in the improvement of the supply of medicines for people in the South.'Sjaak van der Geest, University of Amsterdam